Janwillem Wh Kocks

48PUBLICATIONS
156CO-AUTHORS
Medical virologyPharmaceutical delivery technologiesRespiratory diseasesMedical genetics (excl. cancer genetics)Epidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (48)

|Aug 06, 2026
A phase 2a, double-blind, randomised, placebo-controlled trial of the myeloperoxidase inhibitor, mitiperstat, in participants with chronic obstructive pulmonary disease.

|Jun 12, 2026
Global pMDI Use and the Potential Impact of European PFAS Legislation on Access to These Essential Inhaled Medications.

|Mar 16, 2026
Development and Internal Validation of a Prediction Model for Major Cardiovascular and Respiratory Events in Chronic Obstructive Pulmonary Disease: Nationwide Primary Care Electronic Medical Records Cohort Study.

Chris P Gale, Mohit Bhutani, Jeffrey Shi Kai Chan

|Dec 22, 2025
Derivation and Definitions of Clinical Study Variables for Multiple Long Term Conditions in Patients with Chronic Obstructive Pulmonary Disease: Protocol for a Modified Delphi Methods and Consensus Study on Behalf of the International Cardiovascular and Respiratory Alliance.

Tobin Joseph, Mohit Bhutani, Amy Couper

|Oct 01, 2025
Phase 2a, Randomized Trial of Mitiperstat Versus Placebo in Patients with COPD at High Risk of Exacerbation (CRESCENDO).

Rod Hughes, Wayne Brailsford, João Ferreira

|Sep 18, 2025
Expert Perspectives on Next Generation Health Guidelines: How to Integrate RWE in EBM.

Stefano Del Giacco, Giorgio Walter Canonica, Ioana Agache

Pageof 8

Frequent Collaborators

12 joint publications

David Price

9 joint publications

Niels H Chavannes

5 joint publications

Esther Metting

5 joint publications

Jaime Correia de Sousa